Raymond James Financial »

Travere Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $17M 292k 56.81
2025-06-30 $33k 2.3k 14.80

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p Mcp Etf (IJH)
Wal-Mart Stores (WMT)

View all positions for Raymond James Financial

Top funds holding Travere Therapeutics

Henderson Group
Jupiter Topco
BlackRock
FMR
State Street Corporation
Bank of America Corporation
Vanguard Capital Management
Perceptive Advisors
Nomura Asset Management International
Adage Capital Partners GP
Geode Capital Management
Rock Springs Capital Management
Armistice Capital
Kynam Capital Management
Stephens Investment Management Group

View all funds holding Travere Therapeutics